510(k) Report

510(k) · Cleared

Cleared

Option ELITE Vena Cava Filter System (352506070E 352506100E)

K242612510(k) SpecialCleared Sep 10, 20247-day reviewClass II21 CFR 870.3375

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Argon Medical Devices, Inc. · DTK Filter, Intravascular, Cardiovascular

Cleared on Sep 10, 2024 as substantially equivalent to K133243 (Rex Medical, L.P., 2013) and 1 other predicate after a 7-day review. Its family tree reaches back 8 generations to 1990. 1 of the 27 devices in its family, counting itself, has a Class I recall.

Decided
Sep 10, 2024
Review
7 days
Class
Class II
Product code
DTK
Recalls
None
Predicates
2

Its longest line of descent runs back 8 generations to K901502 (1990). 26 ancestors in all. No later device cites it as a predicate yet. 1 of the 27 devices in this family, counting this one, has a Class I recall.

  1. Root · 8 generations backK901502 Amplatz Goose-Neck SnareMicrovena Corp. · 1990 · Recalled
  2. 7 generations backK972511 Amplatz Goose Neck Snare Kit/ CatheterMicrovena Corp. · 1998 · Recalled
  3. 6 generations backK021441 Radius SnareRadius Medical Technologies, Inc. · 2002
  4. 5 generations backK022201 Radius Micro SnareRadius Medical Technologies, Inc. · 2003
  5. 4 generations backK032426 Gunhter Tulip Vena Cava Mreye Filter and Retrieval SetCook, Inc. · 2003
  6. 3 generations backK081410 Option Vena Cava FilterRex Medical · 2009
  7. 2 generations backK133243 Option Elite Vena Cava Filter SystemRex Medical, L.P. · 2013 · Recalled
  8. 1 generation backK143405 Option (TM) ELITE Vena Cava Filter 100cm SystemRex Medical, L.P. · 2015
  9. This deviceK242612 Option ELITE Vena Cava Filter System (352506070E 352506100E)Argon Medical Devices, Inc. · 2024

Class I recalls in this family

View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K901502Amplatz Goose-Neck SnareMicrovena Corp.19901
−7K972511Amplatz Goose Neck Snare Kit/ CatheterMicrovena Corp.19981
−6K021441Radius SnareRadius Medical Technologies, Inc.2002—
−5K022201Radius Micro SnareRadius Medical Technologies, Inc.2003—
−4K032426Gunhter Tulip Vena Cava Mreye Filter and Retrieval SetCook, Inc.2003—
−3K081410Option Vena Cava FilterRex Medical2009—
−2K133243Option Elite Vena Cava Filter SystemRex Medical, L.P.20132
−1K143405Option (TM) ELITE Vena Cava Filter 100cm SystemRex Medical, L.P.2015—
0 (this device)K242612Option ELITE Vena Cava Filter System (352506070E 352506100E)Argon Medical Devices, Inc.2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199320
199520
199610
199721
199810
200020
200220
200310
200520
200610
200810
FIG. 1 — Lineage of K242612, 1990–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DTK device

  1. #1 K240257 Denali™ Vena Cava Filter System – Femoral and…score 9.9 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K133243Option Elite Vena Cava Filter System
Summary page 5
…uct Code: 21 CFR Part 870.3375 / DTK Classification / Panel: Class II / Cardiovascular Predicate Devices: The Option™ELITE Vena Cava Filter System (K133243, cleared Dec. 17, 2013) and the Option™ELITE Vena Cava Filter 100cm System (K143405, cleared April 16, 2015). Summary of Change:…
Rex Medical, L.P.20132
*K143405Option (TM) ELITE Vena Cava Filter 100cm System
Summary page 5
…ss II / Cardiovascular Predicate Devices: The Option™ELITE Vena Cava Filter System (K133243, cleared Dec. 17, 2013) and the Option™ELITE Vena Cava Filter 100cm System (K143405, cleared April 16, 2015). Summary of Change: No changes have been made to the subject Option Elite Vena Cava Filter System or 10…
Rex Medical, L.P.2015—

Also cleared against K133243: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (1 Class I)

No FDA recall names this device.

Relatives with a Class I recall

Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.

  • K970466Radius Ptca GuidewireRadius Medical Technologies, Inc. · 1997 · 5 generations back · ◆ in the 1997 ancestors bar of FIG. 12 Class I recalls

What does this lineage say?

  • The line of descent spans 34 years and passes through 6 companies; a new generation was cleared every 4.5 years on median.
  • 6 of the 26 ancestors have a recall of any class; 1 has a Class I recall.
  • 1 other device also cites its predicate K133243.

How does its category compare?

All DTK devices

DTK Filter, Intravascular, Cardiovascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2024, this device’s year, is highlighted.

FDA decisions per year · DTK

5in 2024

2007: 32008: 62009: 32010: 32011: 22012: 52013: 32014: 22015: 22016: 32017: 52018: 22021: 22024: 5
2007high 6 (2008) · low 0 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DTK

29in 2024

2007: 87 days median2008: 87 days median2009: 380 days median2010: 50 days median2012: 156 days median2013: 91 days median2016: 84 days median2017: 88 days median2024: 29 days median
2007high 380 (2009) · low 29 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · DTK

1in 2025

2007: 12013: 12015: 12016: 22019: 62022: 22025: 1
2007high 6 (2019) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DTK

432in 2025

2007: 3642008: 3452009: 4562010: 3692011: 4392012: 3512013: 4732014: 4512015: 8592016: 2,5742017: 4,3642018: 3,9382019: 6,4672020: 5,4052021: 5,3572022: 2,1912023: 5832024: 4062025: 432
2007high 6,467 (2019) · low 345 (2008)2025

MAUDE reports naming product code DTK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20073871364
20086870345
200933800456
20103500369
20112—0439
201251560351
20133911473
20142—0451
20152—1859
201638422,574
201758804,364
20182—03,938
20190—66,467
20200—05,405
20212—05,357
20220—22,191
20230—0583
20245290406
20250—1432
20260—0—

What is it indicated for?

The Option™ELITE Filter is indicated for the prevention of recurrent pulmonary embolism (PE) via percutaneous placement in the inferior vena cava (IVC) in the following conditions: • Pulmonary thromboembolism when anticoagulants are contraindicated • Failure of anticoagulant therapy in thromboembolic disease • Emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced • Chronic, recurrent…

Read the full statement (221 words)

The Option™ELITE Filter is indicated for the prevention of recurrent pulmonary embolism (PE) via percutaneous placement in the inferior vena cava (IVC) in the following conditions:

• Pulmonary thromboembolism when anticoagulants are contraindicated

• Failure of anticoagulant therapy in thromboembolic disease

• Emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced

• Chronic, recurrent pulmonary embolism where anticoagulant therapy has failed or is contraindicated

The Option™ELITE Filter may be removed according to the instructions supplied in the Section IX, entitled “Optional Procedure for Filter Retrieval” in patients who no longer require a filter. Retrieval of the filter can only be performed by the jugular approach.

The Option™ELITE Vena Cava Filter 100cm System is indicated for the prevention of recurrent pulmonary embolism (PE) via placement in the vena cava in the following conditions:

• Pulmonary thromboembolism when anticoagulants are contraindicated

• Failure of anticoagulant therapy in thromboembolic disease

• Emergency treatment following massive pulmonary embolism where anticipated benefits of conventional therapy are reduced

• Chronic, recurrent pulmonary embolism where anticoagulant therapy has failed or is contraindicated

The Option™ELITE Filter may be removed according to the instructions supplied in the Section IX, entitled “Optional Procedure for Filter Retrieval” in patients who no longer require a filter. Retrieval of the filter can only be performed by the jugular approach.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K242612: Option ELITE Vena Cava Filter System (352506070E 352506100E).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K242612

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026